Go Deep
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,044 | -2.3 | 1.88 | 0.96 | 1,119.95 |
| Oct 2026 | 19,126 | -2.3 | 1.85 | 0.96 | 1,094.74 |
| Oct 2026 | 19,044 | -2.4 | 1.88 | 0.96 | 1,116.74 |
| Oct 2026 | 19,573 | -2.0 | 1.65 | 0.96 | 972.72 |
| Oct 2026 | 19,643 | -2.0 | 1.61 | 0.96 | 954.80 |
| Oct 2026 | 19,718 | -1.9 | 1.58 | 0.96 | 934.89 |
| Oct 2026 | 19,665 | -2.0 | 1.60 | 0.96 | 946.77 |
| Oct 2026 | 19,771 | -1.9 | 1.56 | 0.96 | 916.53 |
Ginkgo Bioworks Holdings, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 20,156,000.0 | 19,474,000.0 | 33,396,000.0 | 38,837,000.0 |
| Net Profit | -46,710,000.0 | -82,587,000.0 | -80,751,000.0 | -80,755,000.0 |
| EPS | -0.8 | -1.4 | — | -1.4 |
Ginkgo Bioworks Holdings, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 170,155,000.0 | 227,043,000.0 | 251,455,000.0 | 477,706,000.0 | — |
| Net Profit | -312,763,000.0 | -547,029,000.0 | -892,869,000.0 | -2,104,929,000.0 | — |
| EPS | -5.6 | -10.5 | -18.4 | -50.0 | — |
Ginkgo Bioworks Holdings, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,119,696,000.0 | 1,377,449,000.0 | 1,665,342,000.0 | 2,539,321,000.0 | — |
| Total Liabilities | 611,106,000.0 | 661,391,000.0 | 568,190,000.0 | 803,044,000.0 | — |
| Total Equity | 508,590,000.0 | 716,058,000.0 | 1,097,152,000.0 | 1,736,277,000.0 | — |
Owes vs Owns
Ginkgo Bioworks Holdings, Inc. owed $0.58 for every $1 it owned in Jun 2026, up from $0.32 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.55× | 0.48× | 0.34× | 0.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Ginkgo Bioworks Holdings, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 37.7%Receivables 2.2%Fixed assets (tangible) 47.2%Intangible assets 5.1%Long-term investments 1.3%Other assets 6.5%
How it's funded — Dec 2025
Short-term debt 2.0%Long-term debt 37.2%Payables 0.9%Other liabilities 14.3%Shareholders' equity 45.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 422.6 | 561.6 | 944.1 | 1,315.8 |
| Receivables | 24.3 | 22.4 | 17.9 | 84.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 4.4 |
| Fixed assets (tangible) | 528.7 | 598.2 | 395.0 | 718.8 |
| Intangible assets | 56.9 | 72.5 | 132.0 | 171.3 |
| Long-term investments | 14.9 | 48.5 | 77.9 | 111.8 |
| Other assets | 72.3 | 74.3 | 98.4 | 133.3 |
| Liabilities & equity | ||||
| Short-term debt | 22.8 | 29.0 | 17.5 | 29.3 |
| Long-term debt | 417.1 | 438.8 | 221.8 | 413.3 |
| Payables | 10.6 | 14.2 | 9.3 | 10.5 |
| Other liabilities | 160.7 | 179.5 | 319.6 | 350.0 |
| Shareholders' equity | 508.6 | 716.1 | 1,097.2 | 1,736.3 |
| Net tangible assets | 451.7 | 643.5 | 965.2 | 1,565.0 |
Ginkgo Bioworks Holdings, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -171,059,000.0 | -319,585,000.0 | -295,500,000.0 | -252,198,000.0 | — |
| Investing Activities | -240,289,000.0 | -62,236,000.0 | -80,693,000.0 | -67,394,000.0 | — |
| Financing Activities | 17,775,000.0 | -1,739,000.0 | -3,216,000.0 | 95,337,000.0 | — |